SCHEMBL19219043

SCHEMBL19219043

COC(=O)c1cc(C(=O)O)c(OC)cc1OC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.55
ALDH1A1 P00352 3/20 0.55
HPGD P15428 3/20 0.55
GAA P10253 1/20 0.54
LCK P06239 1/20 0.53
FYN P06241 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
HSD17B10 Q99714 4/20 0.49
KMT2A Q03164 2/20 0.49
POLB P06746 3/20 0.47
HTT P42858 1/20 0.46
CYP3A4 P08684 1/20 0.46
FGFR1 P11362 1/20 0.44
SRC P12931 1/20 0.44
MEN1 O00255 1/20 0.44
MAPK1 P28482 1/20 0.44
USP2 O75604 1/20 0.44
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6582726 0.94 LCK (0.60) KDM4EALDH1A1HPGDGAALCK
SCHEMBL12444067 0.89 ALDH1A1 (0.64) KDM4EALDH1A1HPGDLCKFYN
Hydrochloric Acid SCHEMBL28599506 0.87 ALDH1A1 (0.62) KDM4EALDH1A1HPGDLCKFYN
SCHEMBL7466908 0.85 KDM4E (0.68) KDM4EALDH1A1HPGDGAAHSD17B10
SCHEMBL6582728 0.85 KDM4E (0.67) KDM4EALDH1A1HPGDGAALCK
SCHEMBL8900845 0.84 GAA (0.54) KDM4EALDH1A1HPGDGAAHSD17B10
SCHEMBL347214 0.83 LCK (0.73) KDM4EALDH1A1HPGDLCKFYN
SCHEMBL29765241 0.83 LCK (0.73) KDM4EALDH1A1HPGDLCKFYN
SCHEMBL2830233 0.83 LCK (0.72) KDM4EALDH1A1HPGDLCKFYN
SCHEMBL383036 0.82 GAA (0.53) KDM4EALDH1A1HPGDGAALCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170224640-A1 Compounds For Use In Treatment Of Mucositis INNOVATION PHARMACEUTICALS INC. 2017-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170224640-A1 Compounds For Use In Treatment Of Mucositis MUC1, FUT6, MMP8 KDM4E 3761/4885ALDH1A1 1289/4885HPGD 373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.